Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016


  • Products Id :- GDME0225EPD
  • |
  • Pages: 142
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016" provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Abdominal Aortic Stent Grafts under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Abdominal Aortic Stent Grafts Overview 10

3 Products under Development 11

3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 11

3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory 12

3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 13

3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 14

3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 15

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies 16

4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 16

4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 17

5 Abdominal Aortic Stent Grafts Companies and Product Overview 19

5.1 BiFlow Medical Ltd Company Overview 19

5.1.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Bolton Medical, Inc. Company Overview 21

5.2.1 Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Cardiatis SA Company Overview 26

5.3.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 Cardiovate Company Overview 27

5.4.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Cook Medical Incorporated Company Overview 28

5.5.1 Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 Cordis Corporation Company Overview 33

5.6.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 33

5.7 Cytograft Tissue Engineering, Inc. Company Overview 37

5.7.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

5.8 Endologix, Inc. Company Overview 38

5.8.1 Endologix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

5.9 Endoluminal Sciences Pty Ltd. Company Overview 51

5.9.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51

5.10 EndoSpan Ltd Company Overview 52

5.10.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.11 Lombard Medical Technologies Inc. Company Overview 57

5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

5.12 Lombard Medical Technologies Limited Company Overview 62

5.12.1 Lombard Medical Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 62

5.13 Medtronic plc Company Overview 63

5.13.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 63

5.14 MicroPort Scientific Corporation Company Overview 65

5.14.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 65

5.15 St. Jude Medical, Inc. Company Overview 67

5.15.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67

5.16 TriVascular, Inc. Company Overview 69

5.16.1 TriVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

5.17 University of Limerick Company Overview 75

5.17.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 75

5.18 Venus MedTech Company Overview 76

5.18.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 76

5.19 W. L. Gore & Associates, Inc. Company Overview 77

5.19.1 W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

6 Abdominal Aortic Stent Grafts- Recent Developments 81

6.1 Sep 20, 2016: Endologix Reports Positive Clinical Data from Ovation LIFE (Least Invasive Fast-Track EVAR) Study 81

6.2 Sep 18, 2016: MicroPort Endovascular Minos Ultra Low Profile AAA Stent-Graft Completes Patient Enrollment of Pre-market Clinical Trials 82

6.3 Sep 16, 2016: Cardiovate Raises USD0.15 Million in Venture Financing 82

6.4 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 82

6.5 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 83

6.6 Aug 30, 2016: MPSC Announces 2016 Interim Results 83

6.7 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 85

6.8 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2 87

6.9 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2 88

6.10 Aug 22, 2016: Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives 89

6.11 Aug 17, 2016: Endologix Announces First Patients Treated with Ovation Alto Abdominal Stent Graft System 90

6.12 Aug 02, 2016: Endologix Reports Results for the Second Quarter 2016 91

6.13 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 92

6.14 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 93

6.15 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 95

6.16 Jun 16, 2016: Lombard Medical to Initiate the Altura ALTITUDE Global Registry to Evaluate the Treatment of Abdominal Aortic Aneurysms Across a Wide Range of "Real-World" Endovascular Aneurysm Repair Interventions 95

6.17 Jun 13, 2016: Lombard Medical Reports Positive Five-Year Aorfix Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy 96

6.18 Jun 09, 2016: Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy 97

6.19 Jun 08, 2016: Lombard Medical Provides Update on Controlled Launch of the New Altura Endovascular Stent Graft in Europe 98

6.20 Jun 07, 2016: Final Subject Enrolled in Early Feasibility Study of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis 99

6.21 Jun 06, 2016: Lombard Medical Receives Australian Therapeutic Goods Administration (TGA) Approval for the Aorfix Endovascular Stent Graft for the Treatment of Abdominal Aortic Aneurysms 100

6.22 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 100

6.23 Jun 02, 2016: GORE EXCLUDER Conformable AAA Endoprosthesis Obtains CE Mark 101

6.24 Jun 02, 2016: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft Five-Year Clinical Data at the 2016 Society for Vascular Surgery Annual Meeting 101

6.25 May 31, 2016: Lombard Medical Announces Scientific Presentation by Leading Japanese Surgeons on Improving Endovascular Aneurysm Repair (EVAR) Treatment using the Aorfix Endovascular Stent Graft at the 2016 Japanese Society for Vascular Surgery Annual Meeting in To 102

6.26 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 103

6.27 May 26, 2016: Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study 105

6.28 May 19, 2016: Lombard Medical Announces Scientific Presentation on Altura Endograft System at the International Symposium on Endovascular Therapeutics, SITE Update 2016 106

6.29 May 19, 2016: Lombard Medical Announces Presentation on Aorfix Endovascular Stent Graft at the International Symposium on Endovascular Therapeutics 107

6.30 May 17, 2016: Lombard Medical Releases Positive Early Results from the Altura Endograft System Clinical Evaluation 108

6.31 May 16, 2016: Endologix Completes Patient Enrollment in the Ovation LIFE (Least Invasive Fast-Track EVAR) Study 108

6.32 May 13, 2016: MicroPort Attends CICE 2016 109

6.33 May 11, 2016: Lombard Medical Reports 2016 First Quarter Financial Results 109

6.34 May 09, 2016: Endologix Reports Results for the First Quarter 2016 110

6.35 Apr 28, 2016: Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium 112

6.36 Apr 27, 2016: Positive Nellix Clinical Data from the Global Registry and Treatment of Iliac Aneurysm Studies Presented at the 38th Annual Charing Cross Symposium 112

6.37 Apr 27, 2016: Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial 113

6.38 Apr 21, 2016: Lombard Medical Announces Scientific Presentation on Altura Endovascular Stent Graft at the 38th Annual Charing Cross International Symposium 114

6.39 Apr 21, 2016: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft at the 38th Annual Charing Cross International Symposium 115

6.40 Apr 21, 2016: Lombard Medical Announces Scientific Presentations on Altura and Aorfix Endovascular Stent Grafts at the 38th Annual Charing Cross International Symposium 116

6.41 Apr 14, 2016: Lombard Medical Completes First Altura Endovascular Stent Graft Live Case Training Workshop for German Physicians 117

6.42 Apr 11, 2016: Endologix Announces CE Mark for Next-Generation Nellix EndoVascular Aneurysm Sealing System 118

6.43 Apr 04, 2016: Lombard Medical Provides Update on New Altura Endovascular Stent Graft Launch 119

6.44 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 119

6.45 Mar 09, 2016: Lombard Medical Completes First Altura Endovascular Stent Graft Live Case Physician Training Workshop 119

6.46 Mar 08, 2016: Endologix Announces First Patients in Japan Treated With Nellix EndoVascular Aneurysm Sealing System 120

6.47 Mar 03, 2016: Lombard Medicals New Altura Endovascular Stent Graft to be Presented at 9th Annual Houston Aortic Symposium 120

6.48 Feb 29, 2016: Endologix Announces First U.S. Commercial Implant of AFX2 Bifurcated Endograft System 121

6.49 Feb 24, 2016: Lombard Medical Announces First Commercial Altura Endovascular Stent Graft Procedure in Germany Following LINC 121

6.50 Feb 22, 2016: Endologix Reports Results for the Fourth Quarter and Full Year 2015 122

6.51 Feb 16, 2016: GORE EXCLUDER Device Reaches Significant Milestone 123

6.52 Feb 04, 2016: Lombard Medical Announces First Commercial Altura Endovascular Stent Graft Procedure 124

6.53 Jan 27, 2016: Lombard Medical Announces Completion of Altura Endovascular Stent Graft Live Case Presentation at the 12th Annual Leipzig Interventional Course 124

6.54 Jan 21, 2016: Lombard Medical Announces First Ever Altura Endovascular Stent Graft Live Clinical Case Presentation at the 12th Annual Leipzig Interventional Course 125

6.55 Jan 21, 2016: Lombard Medical presents Aorfix Endovascular Stent Graft at the 12th Annual Leipzig Interventional Course 125

6.56 Jan 12, 2016: First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study 126

6.57 Dec 10, 2015: Endologix AFX Endovascular AAA System Receives Shonin Approval for Marketing in Japan 127

6.58 Dec 10, 2015: First Patient Treated in Canada After 2015 In-Country Approval of Cook Medicals Zenith Alpha Abdominal Endovascular Graft 127

6.59 Nov 30, 2015: Three-Year Follow-Up Data From Lombard Medical Aorfix PYTHAGORAS Pivotal Trial Presented at 42nd Annual VEITHsymposium 128

6.60 Nov 19, 2015: Strong Results Reported for the Cordis INCRAFT AAA Stent Graft System with New Four-Year Data from the INNOVATION Trial 129

6.61 Nov 19, 2015: Positive Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at 2015 VEITH Symposium 130

6.62 Nov 18, 2015: Leading Physicians to Initiate ASCEND Registry for Nellix EVAS System 130

6.63 Nov 18, 2015: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft at the 42nd Annual VEITHsymposium 131

6.64 Nov 18, 2015: Lombard Medical Announces Scientific Presentation on Altura Endovascular Stent Graft at the 42nd Annual VEITHsymposium 132

6.65 Nov 17, 2015: Medtronic's Endurant AAA Stent Graft Delivers Durable, Consistent and Proven Outcomes at Four Years in Real-World Setting 133

6.66 Nov 03, 2015: Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015 134

6.67 Oct 26, 2015: Endologix Raises USD125 Million in Public Offering of 3.25% Notes Due 2020 134

6.68 Oct 26, 2015: Endologix Acquires TriVascular Technologies 135

6.69 Oct 26, 2015: Endologix Reports Third Quarter 2015 Financial Results 136

6.70 Oct 16, 2015: Bolton Medical Announces the First Patient Treated with the New TREO Abdominal Stent-Graft System 137

6.71 Oct 15, 2015: EndoSpan Raises USD10 Million in Private Placement of Shares 137

6.72 Oct 12, 2015: Endologix Announces FDA Approval of AFX 2 Bifurcated Endograft System 137

7 Appendix 139

7.1 Methodology 139

7.2 About GlobalData 141

7.3 Contact Us 141

7.4 Disclaimer 142

1.2 List of Figures

Figure 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 11

Figure 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory 12

Figure 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 13

Figure 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 14

Figure 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 15

1.1 List of Tables

Table 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 11

Table 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory 12

Table 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 13

Table 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 14

Table 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 15

Table 6: Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 16

Table 7: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 17

Table 8: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Table 9: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status 19

Table 10: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description 20

Table 11: Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 12: Relay Abdominal Stent Graft - Product Status 21

Table 13: Relay Abdominal Stent Graft - Product Description 22

Table 14: Relay NBS Abdominal Stent Graft - Product Status 22

Table 15: Relay NBS Abdominal Stent Graft - Product Description 22

Table 16: Treovance Abdominal Stent Graft With Navitel Delivery System - Product Status 23

Table 17: Treovance Abdominal Stent Graft With Navitel Delivery System - Product Description 23

Table 18: Bolton Medical, Inc. - Ongoing Clinical Trials Overview 24

Table 19: Treovance Abdominal Stent Graft With Navitel Delivery System - A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-graft with Navitel Delivery System for Patients with Infrarenal Abdominal Aortic Aneurysms 25

Table 20: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 26

Table 21: Cardiatis C5 - Product Status 26

Table 22: Cardiatis C5 - Product Description 26

Table 23: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 27

Table 24: TESAR Stent-Graft - Product Status 27

Table 25: TESAR Stent-Graft - Product Description 27

Table 26: Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 28

Table 27: Zenith p-Branch - Product Status 28

Table 28: Zenith p-Branch - Product Description 29

Table 29: Cook Medical Incorporated - Ongoing Clinical Trials Overview 30

Table 30: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts 31

Table 31: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion 31

Table 32: Zenith p-Branch - Zenith p-Branch Multi-center Study 32

Table 33: Zenith p-Branch - Zenith p-Branch Pivotal Study 32

Table 34: Zenith p-Branch - Zenith p-Branch: Single-center Study 32

Table 35: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 33

Table 36: INCRAFT AAA Stent Graft - Product Status 33

Table 37: INCRAFT AAA Stent Graft - Product Description 34

Table 38: Cordis Corporation - Ongoing Clinical Trials Overview 35

Table 39: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms (INSPIRATION) 36

Table 40: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms 36

Table 41: INCRAFT AAA Stent Graft - Compassionate Use of the Incraft AAA Stent Graft System 36

Table 42: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 43: LifeJacket AAA Stent Graft - Product Status 37

Table 44: LifeJacket AAA Stent Graft - Product Description 37

Table 45: Endologix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 46: AFX2 Bifurcated Endograft System - Product Status 39

Table 47: AFX2 Bifurcated Endograft System - Product Description 39

Table 48: AFX3 - Product Status 40

Table 49: AFX3 - Product Description 40

Table 50: AFX4 - Product Status 41

Table 51: AFX4 - Product Description 41

Table 52: Nellix CHEVAS - Product Status 41

Table 53: Nellix CHEVAS - Product Description 42

Table 54: Nellix EVAS System - Product Status 42

Table 55: Nellix EVAS System - Product Description 42

Table 56: Nellix With Snorkels - Product Status 43

Table 57: Nellix With Snorkels - Product Description 43

Table 58: Nellix2 AAA Endovascular System - Product Status 43

Table 59: Nellix2 AAA Endovascular System - Product Description 44

Table 60: Paravisceral System - Product Status 44

Table 61: Paravisceral System - Product Description 44

Table 62: Ventana 2 - Product Status 45

Table 63: Ventana 2 - Product Description 45

Table 64: Ventana Fenestrated Stent Graft - Product Status 45

Table 65: Ventana Fenestrated Stent Graft - Product Description 46

Table 66: Xpand BX Covered Stent - Product Status 46

Table 67: Xpand BX Covered Stent - Product Description 46

Table 68: Endologix, Inc. - Ongoing Clinical Trials Overview 47

Table 69: Nellix EVAS System - Aneurysm Study for Complex AAA: Evaluation of Nellix Durability 48

Table 70: Nellix EVAS System - Clinical Relevance of Positron Emission Tomography (PET) Imaging Following Endovascular Aneurysm Repair Using the Nellix Endoprosthesis 48

Table 71: Nellix EVAS System - Multicenter, Observational, Post-market, Real World Registry to Assess Outcomes of Patients Treated with the Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 48

Table 72: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study 49

Table 73: Ventana Fenestrated Stent Graft - Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms 50

Table 74: Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51

Table 75: Stent-Graft With Adhesive Delivery Platform - Product Status 51

Table 76: Stent-Graft With Adhesive Delivery Platform - Product Description 51

Table 77: EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Table 78: Horizon AAA Repair System - Product Status 52

Table 79: Horizon AAA Repair System - Product Description 52

Table 80: Nexus - Product Status 53

Table 81: Nexus - Product Description 53

Table 82: EndoSpan Ltd - Ongoing Clinical Trials Overview 54

Table 83: Nexus - Feasibility Clinical Study to Evaluate the Safety and Performance of the NEXUS Aortic Arch Stent Graft System 55

Table 84: Horizon AAA Repair System - A Prospective Open-label Non-randomized Pivotal Study to Evaluate the Safety and Performance of the Horizon Abdominal Aortic Aneurysm (AAA) Stent Graft System 56

Table 85: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

Table 86: Altura Endograft System - Product Status 57

Table 87: Altura Endograft System - Product Description 58

Table 88: Lombard Medical Technologies Inc. - Ongoing Clinical Trials Overview 59

Table 89: Altura Endograft System - Altura Impact on the Treatment of Abdominal Aortic Aneurysms Using a Novel D-stent EVAR Design 60

Table 90: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion (ELEVATEInternational) 60

Table 91: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms 61

Table 92: Lombard Medical Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 62

Table 93: Low Profile Stent Graft - Product Status 62

Table 94: Low Profile Stent Graft - Product Description 62

Table 95: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 96: Endurant Evo AAA Stent Graft System - Product Status 63

Table 97: Endurant Evo AAA Stent Graft System - Product Description 64

Table 98: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 65

Table 99: Minos Ultra Low Profile Abdominal Aortic Aneurysm Stent-Graft - Product Status 65

Table 100: Minos Ultra Low Profile Abdominal Aortic Aneurysm Stent-Graft - Product Description 66

Table 101: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67

Table 102: Amplatzer AAA Vascular Graft - Product Status 67

Table 103: Amplatzer AAA Vascular Graft - Product Description 68

Table 104: TriVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

Table 105: Ovation Alto System - Product Status 69

Table 106: Ovation Alto System - Product Description 70

Table 107: Ovation Prime Abdominal Stent Graft System - Product Status 70

Table 108: Ovation Prime Abdominal Stent Graft System - Product Description 71

Table 109: TriVascular, Inc. - Ongoing Clinical Trials Overview 72

Table 110: Ovation Prime Abdominal Stent Graft System - A Post-market Study to Evaluate the Safety and Performance of the Ovation or Ovation Prime Abdominal Stent Graft System 73

Table 111: Ovation Prime Abdominal Stent Graft System - Least Invasive Fast-track EVAR with the Ovation Prime Abdominal Stent Graft System: LIFE Study 73

Table 112: Ovation Prime Abdominal Stent Graft System - Least Invasive Fast-Track EVAR with the Ovation Prime Abdominal Stent Graft System: TriVascular Canadian LIFE Study 74

Table 113: Ovation Prime Abdominal Stent Graft System - TriVascular Evaluation of Females Who are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair (The LUCY Study) 74

Table 114: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 75

Table 115: Cardiovascular Graft - Product Status 75

Table 116: Cardiovascular Graft - Product Description 75

Table 117: Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 76

Table 118: Tumbao EndoVascular Aortic Repair System - Product Status 76

Table 119: Tumbao EndoVascular Aortic Repair System - Product Description 76

Table 120: W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77

Table 121: GORE EXCLUDER Conformable AAA Endoprosthesis - Product Status 77

Table 122: GORE EXCLUDER Conformable AAA Endoprosthesis - Product Description 78

Table 123: W. L. Gore & Associates, Inc. - Ongoing Clinical Trials Overview 79

Table 124: GORE EXCLUDER Conformable AAA Endoprosthesis - Assessment of the GORE EXCLUDER Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms 80

Table 125: GORE EXCLUDER Conformable AAA Endoprosthesis - GORE EXCLUDER Conformable AAA Endoprosthesis Study in US and Japan 80

Table 126: Glossary 140

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

BiFlow Medical Ltd

Bolton Medical, Inc.

Cardiatis SA

Cardiovate

Cook Medical Incorporated

Cordis Corporation

Cytograft Tissue Engineering, Inc.

Endologix, Inc.

Endoluminal Sciences Pty Ltd.

EndoSpan Ltd

Lombard Medical Technologies Inc.

Lombard Medical Technologies Limited

Medtronic plc

MicroPort Scientific Corporation

St. Jude Medical, Inc.

TriVascular, Inc.

University of Limerick

Venus MedTech

W. L. Gore & Associates, Inc.

select a license

Single User License
USD 4000 INR 290080
Site License
USD 8000 INR 580160
Corporate User License
USD 12000 INR 870240

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com